Global Temperature Sensor Accessories Market Trends 2018 – Outlook 2023, Industry Research With Market Forecast | Air Shower For Laboratory

Jill C. Blumhoff joined the Company as Assistant Controller on October 7, 2007 and thereafter was promoted to positions of greater responsibility in the Accounting and Finance area including Director of Financial Reporting and Director of Finance and IT until reaching her present position of Chief Financial Officer and Vice President of Finance on May 11, 2016. She has been responsible for all aspects of financial reporting and disclosure as well as leading the Company’s efforts in building the financial support structure at BASi. Ms. Blumhoff held various roles of increasing levels of responsibility in financial reporting and analysis at Wabash National Corporation after beginning her career at Ernst & Young LLP. Ms. Blumhoff received a Bachelor of Science degree in accounting from the University of the Illinois at Urbana-Champaign in 1998.

This table compares Indoor Harvest and Curtiss-Wright’s net margins, return on equity and return on assets.

Under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), the U.S. Department of Health and Human Services regulates the disclosure of confidential medical information in the United States. We have had a global privacy policy in place since January 2001 and believe that we are in compliance with HIPAA and current European Union requirements regarding confidential medical information. We continue to monitor our compliance with these regulations, and we intend to take appropriate steps to promote compliance as these and other privacy regulations are revised or additional regulations come into effect.

(e)       the Account Debtor with respect thereto is a resident or citizen of, and is located within, the United States, unless the sale of goods or services giving rise to such Account is on letter of credit, banker’s acceptance or other credit support terms reasonably satisfactory to the Bank;

ITEM 5 – MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

On July 2, 2018, we acquired substantially all of the assets of Seventh Wave Laboratories, LLC, a consulting-based contract research laboratory located in Maryland Heights, Missouri under the terms and conditions of an Asset Purchase Agreement, dated July 2, 2018 (the “Acquisition”). Seventh Wave provides integrated services for discovery and preclinical drug development. In connection with the Acquisition, on July 2, 2018, we entered into an amendment to our credit arrangements with First Internet Bank. Refer to Note 7 and Note 11 to the Consolidated Financial Statements for additional information. We anticipate capitalizing on the collective skill sets, expertise and assets acquired via the Acquisition to expand our service offerings and reach additional clients.

(2)       Commercial general liability insurance naming Landlord and any mortgagees designated by Landlord as additional insureds, with coverage for any loss, cost, damage or liability on account of bodily injury, including death, property damage occurring on or about the Demised Premises or the sidewalks or ways adjacent thereto, premises/operations, products/completed operations and contractual liability with combined single limits of not less than Two Million ($2,000,000) per occurrence, with additional umbrella coverage of not less than One Million ($1,000,000).

4-901.11; Core; Several pans wet on clean dish shelves. Must air-dry. Do not stack wet, spread out on shelves to dry. After cleaning and SANITIZING, EQUIPMENT and UTENSILS Shall be air-dried.

In fiscal 2018, our Services group continued its presence at several important existing customers. In fiscal 2018, one customer accounted for approximately 11.2% of total sales and 4.0% of total trade accounts receivable at September 30, 2018. In fiscal 2017, this customer accounted for approximately 13.1% of total sales and 5.2% of total trade accounts receivable at September 30, 2017. The customer discussed is included in our Services segment. There can be no assurance that our business will move away from dependence upon a limited number of customer relationships.

Section 3.02. Incentive Compensation. The Employee shall be eligible for incentive compensation, payable solely at the discretion of the Company (and as may be subject to repayment in full or in part in the event of a restatement of the Company’s financial statements in accordance with any applicable policy, law or agreement).

Based on our assessment and those criteria, management concluded that the Company maintained effective internal control over financial reporting as of September 30, 2018.

Our Services revenue increased 11.2% in fiscal 2018 to $22,440 compared to $20,182 for the prior fiscal year. Nonclinical services revenues increased due to an overall increase in the number of studies from the prior fiscal year period plus the additional revenues attributable to the Seventh Wave Laboratories acquisition added $1,969 in fiscal 2018. Other laboratory services revenues were negatively impacted by lower discovery and archiving services, which were partially offset by higher pharmaceutical analysis revenues in fiscal 2018. Bioanalytical analysis revenues increased due to the revenues attributable to the Seventh Wave Laboratories acquisition of $884 in fiscal 2018.